Skin cancers

Hedgehog switching helps BCC patients stay on therapy

Two Australian case studies have highlighted the advantage of switching between the two available hedgehog signalling pathway inhibitors in order to minimise drug-related adverse effects. Writing in the Australasian Journal of Dermatology, Dr Matthew Gibson and Professor Dedee Murrell said side effects were common including muscle spasms, alopecia, dysgeusia and weight loss.  And studies have ...

Already a member?

Login to keep reading.

© 2021 the limbic